Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study
Authors:
Open Access
- 23 March 2023
- journal article
- research article
- Published by Elsevier in The Lancet Public Health
- Vol. 8 (4) , e294-e304
Abstract
No abstract availableKeywords
Funding Information
- Canadian HIV Trials Network, Canadian Institutes of Health Research (CTN222)
- Gilead Sciences
- Ministerie van Volksgezondheid, Welzijn en Sport
- Canadian Institutes of Health Research (FDN-143270)
- Swiss HIV Cohort Research Foundation
- Santé
- Department of Health and Ageing, Australian Government
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (201369)
This publication has 21 references indexed in Scilit:
- Hepatitis C Elimination in People With HIV Is Contingent on Closing Gaps in the HIV ContinuumOpen Forum Infectious Diseases, 2019
- Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trialThe Lancet Gastroenterology & Hepatology, 2019
- Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV‐HCV co‐infected patients in CanadaJournal of the International AIDS Society, 2018
- Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort StudyOpen Forum Infectious Diseases, 2018
- High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the NetherlandsClinical Infectious Diseases, 2017
- Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients – French ANRS CO13 HEPAVIH cohortJournal of Hepatology, 2017
- HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western EuropeJournal of Hepatology, 2017
- A longitudinal, HIV care continuumAIDS, 2016
- Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysisThe Lancet Infectious Diseases, 2016
- Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patientsHepatology, 1999